Urology · Houston, TX
NPI
1811087851
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7200 Cambridge St
Houston, TX, 77030
Phone (713) 798-4001
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,932 services
Medicare patients, 2024
332
Average age 73
Drug cost, 2024
$263K
2,169 prescriptions
Company payments, 2025
$11K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Larry I Lipshultz was code 99214 (office e&m - established), 408 times for 262 patients. In total Larry I Lipshultz billed 1,932 services in 61 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 408 | 262 | $85.78 | $35K |
| 82670 Clinical Chemistry | Office | 163 | 126 | $27.10 | $4,418 |
| 84403 Clinical Chemistry | Office | 82 | 73 | $25.07 | $2,056 |
| 84153 Clinical Chemistry | Office | 82 | 69 | $17.81 | $1,461 |
| 99204 Office E&M - New | Office | 35 | 35 | $115.58 | $4,045 |
| 52000 Cystourethroscopy | Office | 34 | 32 | $184.08 | $6,259 |
| 51741 Test - Miscellaneous | Office | 32 | 29 | $9.19 | $294 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | Office | 31 | 31 | $18.92 | $587 |
| 81002 Clinical Chemistry | Office | 29 | 25 | $3.41 | $98.89 |
| 83001 Clinical Chemistry | Office | 28 | 27 | $17.75 | $497 |
| 83002 Clinical Chemistry | Office | 28 | 27 | $17.69 | $495 |
| 99212 Office E&M - Established | Office | 21 | 18 | $43.88 | $922 |
| 93980 Duplex Scan - Extremity Arteries | Office | 17 | 17 | $78.34 | $1,332 |
| 99213 Office E&M - Established | Office | 17 | 17 | $71.02 | $1,207 |
| 51797 Other Organ Systems | Office | 14 | 13 | $150.37 | $2,105 |
By year: 2022 $74K for 1,197 services; 2023 $77K for 1,345 services; 2024 $104K for 1,932 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82670 Clinical Chemistry | 163 | 126 | $27.10 | $4,418 |
| 84153 Clinical Chemistry | 82 | 69 | $17.81 | $1,461 |
| 84403 Clinical Chemistry | 82 | 73 | $25.07 | $2,056 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 31 | 31 | $18.92 | $587 |
| 81002 Clinical Chemistry | 29 | 25 | $3.41 | $98.89 |
| 83002 Clinical Chemistry | 28 | 27 | $17.69 | $495 |
| 83001 Clinical Chemistry | 28 | 27 | $17.75 | $497 |
| 84146 Clinical Chemistry | 14 | 14 | $18.99 | $266 |
| 84154 Clinical Chemistry | 12 | 11 | $18.02 | $216 |
| 86316 Immunoassay | 11 | 11 | $20.39 | $224 |
Medicare prescription drug claims, 2024
In 2024, the drug Larry I Lipshultz prescribed most often to Medicare patients was Anastrozole, with 324 prescriptions and refills. In total Larry I Lipshultz wrote 2,169 Medicare prescriptions that cost $263K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 324 | 836 | 109 | $1,471 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 292 | 731 | 101 | $8,031 |
| Testosterone Cypionate Generic | 252 | 474 | 74 | $13K |
| Tamsulosin Hcl Generic | 180 | 472 | 64 | $3,530 |
| Finasteride Generic | 166 | 453 | 63 | $2,293 |
| Cabergoline Generic | 125 | 245 | 31 | $10K |
| Testosterone Generic | 87 | 126 | 23 | $26K |
| Myrbetriq Mirabegron | 74 | 140 | 19 | $68K |
| Pentoxifylline Generic | 67 | 101 | 15 | $2,380 |
| Dutasteride Generic | 41 | 113 | 14 | $1,651 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 33 | 33 | 31 | $143 |
| Testosterone Enanthate Generic | 30 | 47 | Under 11 | $2,829 |
| Solifenacin Succinate Generic | 30 | 88 | 14 | $2,114 |
| Xyosted Testosterone Enanthate | 26 | 42 | Under 11 | $25K |
| Tadalafil Generic | 25 | 65 | 13 | $6,522 |
Brand drugs: - claims; generic drugs: 2,001 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Larry I Lipshultz $11K ($11K in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $10K.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 6 | $10K |
| Innovation Technologies Inc | 1 | $147 |
| Endo USA, Inc. | 1 | $122 |
| Ferring Pharmaceuticals Inc. | 1 | $83.68 |
| Tolmar, Inc. | 1 | $15.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.